Gantenerumab is a fully human anti-amyloid-beta (Abeta) IgG1 monoclonal antibody demonstrates sustained cerebral amyloid-beta binding. Gantenerumab can be used for Alzheimers disease research.
Purity:
99.5%
CAS Number:
[1043556-46-2]
Target:
Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted